Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: Bdx - You Need To See This

Is ResMed Stock Underperforming the Dow?

While ResMed has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Becton, Dickinson and Company Stock: Is BDX Underperforming the Healthcare Sector?

Although Becton, Dickinson and Company has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Stryker Stock Underperforming the S&P 500?

Despite Stryker’s underperformance relative to the S&P 500 Index over the past year, Wall Street analysts remain highly bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Dividend Kings That Earn Their Crown Every Quarter

These 3 Dividend Kings combine decades of dividend growth with strong fundamentals, recession resistance, and long-term income potential

MarketBeat

Exclusive: BDX Droid figures, a talking Mandalorian, and more Star Wars toys are landing at Disney Store for May the 4th

Disney Store’s May the 4th drop includes exclusive BDX Droid figures, a talking Mandalorian action figure, light-up gauntlets, collectible pins, and more inspired by The Mandalorian and Grogu.

TechRadar

What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release

Becton, Dickinson and Company is set to report its fiscal second-quarter earnings next month, and analysts project a double-digit earnings decline.

Barchart

Southeast Asia could become a booming AI market if its data centers can beat the heat

“You can’t ignore the fact that 85% of the world’s population lives outside temperate regions,” says BDx Data Centers CEO Mayank Shrivastava.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Is Becton, Dickinson and Company Stock Outperforming the Dow?

As Becton, Dickinson and Company has outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Disney Store is finally releasing BDX droids figures — and they look fantastic

Plus, talking figures and RC speeders

TechRadar

Are Wall Street Analysts Bullish on Becton, Dickinson and Company Stock?

Becton, Dickinson and Company has lagged behind the broader market over the past year, yet analysts remain somewhat optimistic about the stock’s prospects.

Barchart

What to Expect From Becton, Dickinson and Company's Next Quarterly Earnings Report

Becton, Dickinson and Company is ready to unveil its fiscal first-quarter earnings soon, and analysts project a double-digit profit drop.

Barchart

Baxter International Stock: Is BAX Underperforming the Health Care Sector?

Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.

Barchart

Is Becton, Dickinson and Company Stock Underperforming the Nasdaq?

Becton, Dickinson and Company has notably underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

TechRadar

Disney's new Olaf robot is so real, it'll give you chills

Disney Imagineering has already created a trove of animatronics and robots, maybe none more lovable than the Star Wars BDX Droids, but this next one is so real that it’s ice cool. Olaf, the walking, talking, and wisecracking snowman we all know from Frozen, is now a reality in the…

Barchart

What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?

Although Becton, Dickinson and Company has underperformed the broader market over the past year, Wall Street analysts maintain a measured optimism about the company’s long-term outlook.

Benzinga

Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal

Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92.

Barchart

Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report

Becton, Dickinson & Company is gearing up to announce its Q4 results next month, with analysts calling for a slight dip in profits.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

BD CFO Set To Exit Company This December, Stock Falls

BD (Becton, Dickinson and Company) (NYSE:BDX) on Wednesday said Chris DelOrefice, executive vice president and chief financial officer (CFO), will depart the company effective December 5.

Barchart

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Despite Becton, Dickinson and Company’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Is Intuitive Surgical Stock Underperforming the S&P 500?

Whereas Intuitive Surgical has delivered weaker returns than the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart

Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Benzinga

Becton Dickinson Q3 Beats Estimates On Medical Device Boom

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their resilience and strategic adaptability. The company’s stock is trading higher on Thursday on better-than-expected third-quarter 2025 earnings.

Barchart

Earnings Preview: What to Expect From Becton, Dickinson and Company's Report

Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Benzinga

Becton's Biosciences And Diagnostics Arm Slated To Join Waters In $17.5 Billion Merger

Becton, Dickinson and Company (NYSE:BDX) has agreed to combine its Biosciences Diagnostic Solutions business with Waters Corporation (NYSE:WAT).

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.